Telehealth ADHD Prescribing: What PMHNPs Can Do in Georgia

If you’re a psychiatrist or PMHNP considering telehealth ADHD care, you’ve probably searched some version of this: ‘Can I legally prescribe Adderall through a video visit?’ The answer is yes — but with important caveats that depend on where you practice and your credential type.

As of early 2026, psychiatrists across the U.S. can prescribe ADHD medications via telehealth under extended federal flexibilities. However, regulatory uncertainty looms, state laws vary significantly, and the rules for PMHNPs versus psychiatrists are night and day in some states.

This guide cuts through the complexity. We’ll cover what psychiatrists can do via telehealth for ADHD, how PMHNP authority differs state by state, what reimbursement looks like, and the practical workflows you need to stay compliant and build a sustainable practice.

The Federal Landscape: Extended Flexibilities Through 2025 (But What’s Next?)

Before the pandemic, the Ryan Haight Act required an in-person medical evaluation before any provider could prescribe Schedule II controlled substances like Adderall or Ritalin via telemedicine. COVID-19 changed that overnight.

The DEA issued emergency waivers allowing providers to initiate stimulant prescriptions through telehealth without an in-person visit. That flexibility has been extended multiple times — most recently through December 31, 2025. This is the third temporary extension, pushing the decision point into late 2025.

What this means for you right now: As a fully licensed psychiatrist, you can conduct an initial ADHD evaluation via video, establish a diagnosis, and e-prescribe stimulants to a new patient — all without requiring an in-person exam first. Standard of care still applies (thorough assessment, documentation, safety monitoring), but the federal legal barrier is lifted.

The uncertainty: Unless Congress passes permanent telehealth prescribing legislation or the DEA finalizes new rules, the default in-person requirement could return in 2026. There’s been discussion of a ‘special registration’ pathway for telemedicine providers, but nothing concrete has been implemented. Keep an eye on DEA rulemaking — your ability to serve new ADHD patients remotely may hinge on policy decisions made in the next 12 months.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Do: Full Authority in Every State

If you’re a psychiatrist (MD or DO), your scope is straightforward: you have unrestricted prescriptive authority in every state for ADHD medications, subject only to federal controlled substance laws and state licensing.

Clinically, you can:

• Conduct comprehensive ADHD evaluations via video (clinical interview, rating scales, collateral information)
• Diagnose ADHD using DSM-5 criteria through telemedicine assessment
• E-prescribe any FDA-approved ADHD medication (stimulants like Adderall, Vyvanse, Ritalin; non-stimulants like Strattera, Intuniv)
• Manage ongoing medication adjustments and monitoring through virtual follow-ups
• Order any necessary baseline or follow-up testing (coordinate with patient’s PCP for vitals, labs if needed)

No supervision required. No collaborative agreements. No quantity limits imposed by your license type. The only constraints are federal DEA requirements (valid registration, PDMP checks where mandated) and state-specific telehealth rules.

State-Specific Telehealth Rules for Psychiatrists

While your prescriptive authority doesn’t change, some states have telehealth-specific requirements:

Florida explicitly allows telehealth prescribing of Schedule II stimulants for psychiatric disorders — essentially codifying what the federal waiver permits. As long as you’re treating ADHD (a psych condition), you can prescribe stimulants via video in Florida.

Texas allows telehealth prescribing for mental health but prohibits prescribing controlled substances via telehealth for chronic pain management. ADHD isn’t pain management, so you’re clear — just ensure you’re using synchronous video (not audio-only) to meet Texas medical board standards.

California, New York, Pennsylvania, Illinois generally defer to federal rules for controlled substance prescribing. No additional state-level in-person requirements beyond the Ryan Haight Act (currently waived). However, you must be licensed in the state where your patient is located and follow any state-specific documentation or consent requirements.

Key compliance steps across all states:

• Check your state’s Prescription Drug Monitoring Program (PDMP) before prescribing. Some states like New York mandate PDMP checks for every Schedule II prescription.
• Use DEA-compliant e-prescribing systems (two-factor authentication required for controlled substances)
• Document that the telehealth encounter met standard of care (thorough evaluation, informed consent, emergency protocols)
• Verify patient identity and location at each visit

PMHNP vs. Psychiatrist: Prescribing Authority Varies Dramatically by State

If you’re a Psychiatric Mental Health Nurse Practitioner, your ability to prescribe ADHD medications independently depends entirely on which state you practice in. Unlike psychiatrists who have uniform authority, PMHNPs face a patchwork of regulations.

Full Practice States (PMHNPs Can Prescribe Stimulants Independently)

New York: After completing 3,600 hours of supervised practice (roughly 2 years), PMHNPs can practice and prescribe completely independently, including Schedule II stimulants. No ongoing physician oversight required. During the initial 3,600 hours, you need a written collaborative agreement with a physician.

Illinois: PMHNPs can obtain Full Practice Authority after 4,000 clinical hours plus 250 hours of additional training. Once granted FPA, you can prescribe all ADHD medications without a collaborative agreement. Prior to FPA, you need a written agreement with a physician who must specifically delegate Schedule II prescribing authority.

California: Transitioning to independence. Experienced NPs (≥3 years/4,600 hours) can apply for independent ‘104 NP’ status as of 2023. Until then, you need physician supervision. Even independent NPs must complete a specialized pharmacology course to prescribe Schedule II medications. This is a state in flux — by 2026, many PMHNPs will be practicing independently, but newer grads still need supervision.

Restricted Practice States (Physician Oversight Required)

Texas: The most restrictive state on our list. PMHNPs cannot prescribe Schedule II stimulants outside of hospital, emergency, or hospice settings — period. Even with a collaborative agreement, you cannot write an outpatient Adderall prescription. Only physicians can prescribe stimulants for routine ADHD care in Texas. PMHNPs can still evaluate patients, provide therapy, and manage non-stimulant medications, but an MD must handle the controlled substances.

Florida: PMHNPs must have a written protocol with a supervising physician (must be a psychiatrist for psychiatric APRNs). General rule: APRNs can only prescribe 7-day supplies of Schedule II drugs. However, Florida carved out an exception for ‘psychiatric nurses’ treating mental health conditions — if you’re a certified PMHNP working under a psychiatrist’s protocol, you can prescribe 30-day supplies of stimulants for ADHD. The collaboration is still mandatory, but the 7-day limit doesn’t apply to psych meds.

Pennsylvania: PMHNPs require a collaborative agreement with a physician. For Schedule II medications, you can prescribe an initial 72-hour supply for a new patient or new condition (must notify physician within 24 hours). For ongoing therapy, you can prescribe up to 30-day supplies, but the patient must be re-evaluated by the collaborating physician before extending beyond 30 days. This creates workflow complexity — many PA practices have the physician handle initial stimulant prescriptions, then the PMHNP manages monthly refills.

Practical Implications

If you’re a PMHNP in Texas or a similarly restricted state and you join a telehealth platform, you’ll need a collaborating psychiatrist on the platform to write stimulant prescriptions. You can handle the clinical evaluation, therapy, and follow-up, but the MD is essential for controlled substance prescribing.

In contrast, if you’re an experienced PMHNP with independent authority in New York or Illinois, you can build a full ADHD medication management practice on your own — seeing patients, diagnosing, prescribing stimulants, and managing ongoing care without physician involvement.

Bottom line: Your scope of practice for ADHD care may be limited by state law, not your clinical competency. Before joining any telehealth platform or expanding your practice, verify your state’s current NP scope and whether you’ll need a collaborating physician.

Collaborative Practice Agreements: What They Mean in Practice

In states requiring physician collaboration, the agreement typically outlines:

• Scope of services: What diagnoses and treatments the NP can manage (should include ADHD and psychotropic medications)
• Prescriptive authority: Which medications the NP can prescribe (many agreements explicitly list Schedule II stimulants or delegate broad authority)
• Communication protocols: How often the NP and physician will consult (monthly meetings, chart reviews, etc.)
• Supervision ratios: State limits on how many NPs one physician can oversee (e.g., 4 in Florida, 7 in Texas)

In telehealth settings, these agreements work similarly to in-person practice. The collaborating physician doesn’t need to be in the same physical location or see every patient. What matters is documented oversight — periodic case discussions, availability for consultation, and chart review per state requirements.

For platforms like Klarity Health, this might mean psychiatrists are paired with PMHNPs to extend reach in restricted states: the PMHNP handles the bulk of patient care while the MD provides prescriptive authority and supervision as required by law.

Telehealth Workflows for ADHD Medication Management

Managing ADHD via telemedicine requires careful adherence to clinical standards. Here’s what a typical workflow looks like:

Initial Evaluation (45-60 minutes):

• Comprehensive psychiatric interview via video
• ADHD symptom assessment using standardized rating scales (ASRS for adults, Vanderbilt or Conners for children/adolescents)
• Review of collateral information (school reports, prior records, family input)
• Mental status exam and screening for comorbidities (anxiety, depression, substance use)
• Discussion of treatment options, risks/benefits of stimulant therapy
• Informed consent covering medication risks, treatment plan, emergency protocols

Baseline Safety Steps:

• Coordinate with patient’s primary care provider for baseline vitals (BP, heart rate) — or ask patient to obtain at a pharmacy
• Review cardiac history; consider EKG if warranted (older patients, known cardiac issues)
• Check state PDMP for any concerning overlapping controlled substance prescriptions
• Document patient identity verification and location (for licensure compliance)

E-Prescribing:

• Use DEA-compliant electronic prescribing platform with two-factor authentication
• Start with lower doses (e.g., 10mg Adderall XR or 18mg Concerta) unless patient has documented tolerance
• Schedule II stimulants cannot be prescribed with refills — each month requires a new prescription
• Note: some state Medicaid programs or insurers require prior authorization for brand-name stimulants or higher doses

Follow-Up Visits (15-30 minutes, typically monthly):

• Symptom monitoring: effectiveness, side effects, adherence
• Vital sign review (many providers ask patients to self-monitor BP at home)
• PDMP check (required in some states at each visit or at least quarterly)
• Dose adjustments as needed
• Screen for diversion risk or misuse (if any red flags, consider urine drug screen or more frequent visits)

Documentation Best Practices:

• Every visit note should justify medical necessity for controlled substance
• Document objective findings (not just ‘patient reports improvement’ — specify functional improvements in work, school, relationships)
• Note any side effects addressed and risk mitigation strategies
• If providing care across state lines, document which state the patient is in for each visit

Coordination with Other Providers:

• Communicate with patient’s PCP, especially if managing comorbid medical conditions
• If patient also sees a therapist, coordinate care (many ADHD patients benefit from CBT or coaching in addition to meds)
• For pediatric ADHD, obtain teacher input via rating scales or school reports when possible

Reimbursement for Telehealth ADHD Medication Management: What to Expect

One of the most common questions providers have: Will I actually get paid fairly for telehealth visits?

The short answer: Yes, thanks to widespread parity laws.

Telehealth Parity is Nearly Universal in 2026

Nearly 48 states have enacted telehealth parity policies — meaning insurers must reimburse virtual mental health visits at the same rate as in-person visits. This includes both commercial insurance and Medicaid in most states.

Medicare has extended telehealth coverage for mental health services through at least 2024, with strong congressional support for further extensions. Medicare pays for telehealth psychiatric services at the non-facility rate — the same as if you saw the patient in your office.

Private insurance generally follows Medicare’s lead, with most major carriers (Anthem, UnitedHealthcare, Aetna, etc.) paying equivalent rates for telepsych visits.

What You Can Expect to Earn Per Visit

Psychiatrists typically bill Evaluation & Management (E/M) codes for medication management:

CPT 99213 (15-minute established patient visit, low-moderate complexity):

• Medicare: ~$89-95
• Commercial insurance: Often $100-130 (varies by payer and region)
• Medicaid: Typically $40-65 (significantly lower, but still covers cost)

CPT 99214 (25-minute established patient visit, moderate complexity):

• Medicare: ~$125-136
• Commercial insurance: $140-180
• Medicaid: $60-85

CPT 90792 (Initial psychiatric diagnostic evaluation, 45-60 minutes):

• Medicare: ~$188-202
• Commercial insurance: $200-300+
• Medicaid: ~$100-150

What this means for your income: If you see four patients per hour for medication management (15-minute visits), you’re looking at roughly $360-520/hour gross revenue depending on payer mix. Telehealth eliminates office overhead, commute time, and no-show rates often drop (easier for patients to keep virtual appointments), so your net income per hour can actually be higher than traditional practice.

Psychiatrists vs. Other Providers

Psychiatrists are reimbursed at higher rates than most other mental health providers for medication management services. This reflects your medical training and prescriptive authority.

PMHNPs may be reimbursed at 85% of physician rates under Medicare if billing under their own NPI (some practices bill ‘incident to’ the physician to get full rates, but this is complex and often doesn’t apply in telehealth). Commercial payers vary — some credential NPs at lower fee schedules, others pay the same.

The advantage for psychiatrists: Insurers recognize your MD/DO license as the highest level of qualification for medication management, which translates to better reimbursement and fewer credentialing hurdles.

State-Specific Considerations

High-paying markets: New York, California, and Illinois tend to have higher commercial reimbursement rates due to cost of living adjustments. A 99214 might pay $150-180 from private payers in these states.

Lower Medicaid rates: States like Texas and Florida have Medicaid programs that pay on the lower end (~$40-60 for a 99213). If you’re seeing a high volume of Medicaid patients, factor that into your practice model.

Cash-pay options: Many ADHD patients are willing to pay out-of-pocket for convenient telehealth access, especially if local wait times are months long. Cash rates for ADHD med management typically range from $150-300 for initial evaluations and $75-150 for follow-ups, depending on market and your positioning.

Billing Compliance Tips

• Use telehealth modifiers: Most payers require you to indicate a telehealth visit (Place of Service code 02 or modifier 95) to process claims correctly
• Document patient consent: Some states require documented verbal or written consent for telehealth billing
• Prior authorizations: Stimulants often require prior auth, especially for brand-name or higher doses. Factor in the administrative time or have support staff handle this
• Avoid surprise billing: The No Surprises Act requires Good Faith Estimates for cash-pay patients; make sure your billing practices comply

State Market Conditions: Where the Opportunity Is

Provider supply and demand vary dramatically by state, affecting both your patient volume and competitive landscape.

High-Demand, Underserved Markets

Texas: Severe psychiatrist shortage — approximately 1 psychiatrist per 9,000 residents (one of the worst ratios in the country). Over 185 of Texas’s 254 counties are designated mental health shortage areas. Huge demand for telehealth ADHD services, but restrictive NP laws mean psychiatrists are especially needed. If you’re an MD licensed in Texas, you can quickly build a full caseload.

Florida: About 1 psychiatrist per 8,500 residents — also significantly undersupplied. High population growth, large pediatric and young adult population. Strong telehealth adoption. Competitive landscape includes national telehealth companies, but demand still exceeds supply in many regions (especially North Florida and rural areas).

Pennsylvania: Moderate shortage, especially in rural areas outside Philadelphia and Pittsburgh (1 psychiatrist per ~4,600 residents overall, but very uneven distribution). Strong insurance coverage (Medicaid and commercial), good telehealth infrastructure. NP collaborative requirements create opportunities for psychiatrists willing to supervise PMHNPs.

Well-Supplied But Still High-Demand Markets

New York: Best psychiatrist ratio in the country (~1 per 2,900 residents), largely due to NYC concentration. However, upstate rural areas are still shortage zones. High competition in NYC metro but also sophisticated patient base willing to pay for convenience and quality. Telehealth helps serve underserved upstate communities from anywhere in the state.

California: Largest absolute number of psychiatrists, but still about 1 per 5,000 residents — adequate in cities, shortage in rural Central Valley and Inland Empire. Progressive regulatory environment, moving toward NP independence. Large tech-savvy population, high demand for adult ADHD services. Competitive but huge market.

Illinois: About 1 psychiatrist per 5,800 residents — adequate in Chicago, shortage downstate. NP Full Practice Authority increasing supply of independent PMHNPs. Strong telehealth parity and insurance coverage. Good market for providers willing to serve Medicaid population (which many private providers don’t).

Key Takeaway

States with the worst shortages (Texas, Florida) offer the most immediate opportunity for psychiatrists but come with regulatory complexity for PMHNPs. States with better supply (New York, California) are more competitive but offer larger patient bases, better reimbursement, and more progressive scope-of-practice laws.

Provider Pain Points: What You Need to Know Before Diving In

ADHD telehealth prescribing isn’t without challenges. Here are the common pain points providers face and how to navigate them:

Regulatory Uncertainty

The biggest frustration: you’re operating under temporary federal rules that could change. The December 2025 deadline for the DEA telehealth waiver means you may need contingency plans for 2026 — like partnering with local clinics for in-person exams if required.

Solution: Stay informed on federal policy. Subscribe to DEA updates, join professional organizations (APA, AACAP) that track regulatory changes. Build flexibility into your practice model.

ADHD Medication Shortages

Stimulant shortages have been ongoing since late 2022. Patients frequently can’t fill prescriptions because pharmacies are out of stock. This creates frustration, extra phone calls, and requires switching medications or finding alternative pharmacies mid-treatment.

Solution: Educate patients upfront about potential supply issues. Have backup medication options ready (different formulations, non-stimulants). Build relationships with mail-order pharmacies that may have better supply chains. Document shortages in your notes as medical necessity for medication switches.

Higher Scrutiny and Liability Concerns

High-profile cases of telehealth companies overprescribing stimulants have put ADHD tele-prescribing under a microscope. Some providers worry about being seen as ‘pill mills’ or facing board investigations.

Solution: Practice defensively — thorough documentation, standardized assessment tools, regular follow-ups, PDMP checks. Avoid red flags like prescribing high doses to new patients without clear justification, skipping mental status exams, or failing to assess for comorbidities. If something feels off about a patient (possible diversion, drug-seeking behavior), trust your clinical judgment and either refuse to prescribe or taper them off.

Managing Comorbidities Remotely

Adult ADHD often comes with anxiety, depression, or substance use issues. Assessing and managing these via video can be trickier than in-person, especially if you can’t do a physical exam or observe the patient in a waiting room setting.

Solution: Use structured screening tools (PHQ-9 for depression, GAD-7 for anxiety, AUDIT for alcohol). Obtain collateral information when possible. Consider requiring an in-person visit with the patient’s PCP for complex cases. Coordinate care with therapists who may see the patient more frequently.

State-by-State Licensing and Scope Navigation

Practicing across state lines means managing multiple licenses, tracking different PDMP requirements, and understanding varying NP scope laws. It’s administratively heavy.

Solution: Many telehealth platforms handle credentialing and keep you informed of state-specific requirements. If you’re building your own practice, consider focusing on 1-3 states initially rather than trying to be licensed everywhere. Use interstate compacts where available (Interstate Medical Licensure Compact for physicians).

The Economics of Telehealth ADHD Practice: Why Platforms Like Klarity Make Sense

Let’s talk about the real cost of acquiring ADHD patients on your own versus joining a platform.

The DIY Marketing Reality Check

If you decide to build your own telehealth ADHD practice from scratch, here’s what patient acquisition actually costs:

SEO (Search Engine Optimization): 6-12 months of consistent investment before meaningful results. You’ll need a website, content creation, backlinks — either hire an agency ($2,000-5,000/month) or spend dozens of hours doing it yourself. Even then, you’re competing with established practices and directories.

Google Ads: Mental health keywords are expensive ($15-40+ per click). Most clicks don’t convert to booked patients. Realistic cost per booked patient through PPC: $200-400+ when you factor in ad spend, campaign optimization, and conversion rates.

Directory Listings (Psychology Today, Zocdoc, etc.): Monthly fees ($30-100/month per directory) plus listing fees. Zocdoc charges $35-100+ per booking. You’re also competing with hundreds of other providers on the same page. Total monthly cost can easily hit $300-500 for minimal return.

No-shows and unqualified leads: Cold leads from DIY marketing have higher no-show rates (20-40% is common). Each no-show is wasted time and lost revenue.

Bottom line: Acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ when you account for ALL costs — agency fees, ad spend, staff time to handle leads, failed campaigns, months of SEO investment before results, and no-show rates from cold leads.

Most solo providers don’t have the expertise, budget, or patience for this. SEO is a long game. PPC requires constant optimization. And you’re competing with well-funded telehealth companies that outbid you on ads.

The Klarity Model: Pay Only When You See Patients

Klarity Health uses a pay-per-appointment model — similar to how Zocdoc works, but specifically designed for psychiatric providers.

How it works:

• No upfront marketing costs or monthly subscription fees
• Klarity matches you with pre-qualified patients who are already seeking ADHD care and fit your availability and specialty
• You pay a standard listing fee per new patient lead (only when a patient books with you)
• Built-in telehealth platform (no separate EMR or video software costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you actually see patients

The value proposition:Instead of gambling $3,000-5,000/month on marketing with uncertain ROI, you pay only when a qualified patient shows up. That’s guaranteed ROI — your cost per patient is fixed and predictable.

For new providers or those scaling: Klarity removes the biggest risk in building a practice — patient acquisition. You can focus entirely on clinical care while the platform handles marketing, credentialing, and patient matching.

For established providers: Klarity fills gaps in your schedule without you having to ramp up your own marketing. It’s supplemental patient flow with zero waste.

The Numbers Compared

DIY Practice (conservative estimate):

• Marketing spend: $3,000-4,000/month
• Time investment: 10-20 hours/month (managing ads, SEO, directories, lead follow-up)
• New patient acquisition: Maybe 5-10 patients/month after 6+ months of consistent effort
• Cost per patient: $300-800 all-in
• Risk: High (no guarantee of results; market saturation)

Platform Model (Klarity):

• Marketing spend: $0
• Time investment: 0 (platform handles it)
• New patient acquisition: Variable based on your availability and demand in your state
• Cost per patient: Standard listing fee (disclosed upfront)
• Risk: Zero (you only pay when patients book)

The smart economic choice: Platform models make sense for most providers because they eliminate upfront risk, provide predictable patient flow, and let you focus on what you do best — clinical care.

FAQ: ADHD Telehealth Prescribing

Can I prescribe Adderall to a patient I’ve never met in person?

Yes, as of 2026 — under the extended federal telehealth waiver through December 31, 2025 (and likely beyond). You must conduct a thorough video evaluation that meets the same standard of care as an in-person visit. After 2025, this depends on whether federal rules are extended or finalized.

Do I need to check the state prescription monitoring program every time I prescribe stimulants?

It depends on your state. New York requires PDMP checks for every Schedule II prescription. Other states require checks at the start of therapy and then every 3 months or ‘as clinically appropriate.’ Check your state medical board guidelines — but best practice is to check at each visit or at minimum before each new prescription.

Can PMHNPs prescribe ADHD medications independently in every state?

No. NP prescribing authority varies by state. In Full Practice states like New York (after 3,600 hours) and Illinois (with FPA certification), PMHNPs can prescribe stimulants independently. In restricted states like Texas and Florida, PMHNPs need physician oversight and may face additional limitations (Texas NPs cannot prescribe Schedule II stimulants outside hospital settings at all).

What if my state’s telehealth rules change and require in-person exams again?

If federal waivers expire and your state doesn’t have its own telehealth prescribing allowance, you may need to see new ADHD patients in person for at least one visit before initiating stimulants. For existing patients you’ve already evaluated virtually, you can likely continue managing them remotely. Consider partnering with local clinics or mobile providers who can do in-person visits when needed.

What’s the difference in reimbursement between treating ADHD in-person versus via telehealth?

Virtually none as of 2026, thanks to telehealth parity laws. Medicare, Medicaid (in most states), and commercial insurers pay the same rates for telehealth psychiatric visits as in-person. Use the appropriate place of service code or telehealth modifier, but the fee schedule is the same.

Can I treat ADHD patients in multiple states through telehealth?

Yes, but you need a medical license in every state where your patients are located. You cannot practice across state lines with just one license (except in very limited compact situations). Each state also has its own prescribing and telehealth rules, so you’ll need to stay compliant with each jurisdiction’s requirements.

How do I handle ADHD medication shortages when patients can’t fill prescriptions?

Document the shortage in your chart notes. Consider prescribing alternative formulations (e.g., generic amphetamine salts if Adderall is unavailable, or immediate-release if extended-release is out of stock). Build relationships with mail-order pharmacies or have patients try multiple local pharmacies. In some cases, you may need to switch to a non-stimulant like atomoxetine or bupropion temporarily.

What should I do if I suspect a patient is misusing or diverting their ADHD medication?

Trust your clinical judgment. Warning signs include: requesting early refills, losing prescriptions frequently, escalating dose requests without clinical justification, erratic behavior, or signs of stimulant intoxication. If you suspect diversion, you can: refuse to continue prescribing, require more frequent visits and pill counts, order urine drug screens, or transition to a non-stimulant. Document everything. You’re not required to continue prescribing if you’re uncomfortable — and state medical boards expect you to exercise appropriate caution with controlled substances.

Ready to Build a Sustainable ADHD Telehealth Practice?

The demand for ADHD care has never been higher. Patients are waiting months for appointments. Stimulant prescriptions have surged. And telehealth has made psychiatric care more accessible than ever.

But building a practice from scratch — navigating state regulations, marketing to patients, managing credentialing and billing — is time-consuming and risky.

Klarity Health offers a better path: Join a platform where the patient acquisition, compliance support, and infrastructure are already built. You focus on clinical care. We handle the rest.

Whether you’re a psychiatrist with full prescriptive authority or a PMHNP looking for collaborative support in a restricted state, Klarity connects you with patients who need you — without the overhead, uncertainty, or wasted marketing spend.

Ready to explore? Learn more about joining Klarity’s provider network and start seeing ADHD patients on your schedule, with zero upfront investment.

Sources and Citations

The following sources were used to compile this guide. Each is categorized by type, dated, and assessed for reliability:

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the